Skip to main content
Premium Trial:

Request an Annual Quote

Mt. Sinai to Install Agilent Mass Spectrometer

NEW YORK (GenomeWeb News) – Mount Sinai School of Medicine will install an Agilent 6460 triple-quadrupole mass spectrometer for use by members of the Academy for Medical Development and Collaboration, or AMDeC, the academy said today.

AMDeC, which includes 28 member institutes in New York, acquired the mass spectrometer through a purchasing agreement with Agilent.

These member institutes will use the mass spectrometer at Mt. Sinai for a range of research applications, including proteomics studies aimed at discovering clinically relevant biomarkers, measuring environmental and food contaminants, and quantifying pharmaceutical candidates.

"This is another example of how AMDeC has taken a proactive approach to bringing researchers together and equipping them with what they need to drive their programs," Maria Mitchell, AMDeC's president and CEO, said in a statement.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.